Search Results 611-620 of 16311 for infliximab
1 Diabetes (T1D). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
About this study. To determine the antitumor activity of tipifarnib in patients with locally advanced unresectable or metastatic, relapsed and/or refractory ...
The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab ...
Cisplatin injection is used to treat advanced cancer of the bladder, ovaries, or testicles. Cisplatin is an antineoplastic agent (cancer medicine). It ...
A Multi-center Study A Single IV Infusion Of Allogeneic MPCs In Patients With Rheumatoid Arthritis And Incomplete Response To At Least One TNF Alpha Inhibitor.
A side effect is anything a drug does to the body besides treating the disease. Participants will have cancer that has spread in the body near where it started ...
Key Inclusion Criteria: Participants must have completed the AG10-501 study (ACT-EARLY study) within the past 60 calendar days with a diagnosis of ATTR-CM ...
CT chest scan, PET-CT scan and transbronchoscopic biopsy indicating immune-mediated adverse events. Share · Tweet . IMG-20400457.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!